CONFERENCE COMMITTEE REP. NO.81
Honolulu, Hawaii
, 2001
RE: H.B. No. 644
H.D. 1
S.D. 2
C.D. 1
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-First State Legislature
Regular Session of 2001
State of Hawaii
Honorable Robert Bunda
President of the Senate
Twenty-First State Legislature
Regular Session of 2001
State of Hawaii
Sir:
Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 644, H.D. 1, S.D. 2, entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"
having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.
The purpose of this bill is to:
(1) Authorize electronic transmission and recordkeeping of prescription information;
(2) Exempt donors of pharmaceuticals from civil liability; and
(3) Repeal guidelines regarding the return of prescription drugs.
Your Committee on Conference has amended this bill by removing Part I, which authorizes the electronic transmission and recordkeeping of prescription information, because its contents are similar to its companion measure, S.B. No. 1119, which has passed out of Conference Committee.
Your Committee on Conference has further amended this bill by:
(1) Inserting the definitions of "needy person", "pharmaceuticals and health care supplies", "pharmaceutical company", and "pharmacy" to further clarify the contents of this bill; and
(2) Changing the effective date from July 1, 2050, to upon its approval.
As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 644, H.D. 1, S.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 644, H.D. 1, S.D. 2, C.D. 1.
Respectfully submitted on behalf of the managers:
ON THE PART OF THE SENATE |
ON THE PART OF THE HOUSE |
____________________________ DAVID M. MATSUURA, Chair |
____________________________ KENNETH T. HIRAKI, Co-Chair |
|
____________________________ RON MENOR, Co-Chair |
____________________________ NATHAN SUZUKI, Co-Chair |
|